![]() DRF-1042 structure
|
Common Name | DRF-1042 | ||
---|---|---|---|---|
CAS Number | 200619-13-2 | Molecular Weight | 408.404 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 844.6±65.0 °C at 760 mmHg | |
Molecular Formula | C22H20N2O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 464.6±34.3 °C |
Use of DRF-1042DRF-1042 is an orally active camptothecin analog, which acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines[1][2]. |
Name | drf-1042 |
---|---|
Synonym | More Synonyms |
Description | DRF-1042 is an orally active camptothecin analog, which acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 844.6±65.0 °C at 760 mmHg |
Molecular Formula | C22H20N2O6 |
Molecular Weight | 408.404 |
Flash Point | 464.6±34.3 °C |
Exact Mass | 408.132141 |
PSA | 110.88000 |
LogP | 0.60 |
Vapour Pressure | 0.0±3.3 mmHg at 25°C |
Index of Refraction | 1.726 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-12-(2-hydroxyethoxy)-, (4S,12S)- |
(4S,12S)-4-Ethyl-4-hydroxy-12-(2-hydroxyethoxy)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
5-(2'-Hydroxyethoxy)-20(S)-camptothecin |
1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-12-(2-hydroxyethoxy)-,(4S) |
UNII-461WVF206P |